About Bruno Correia
Bruno Correia completed his PhD at the Instituto de Tecnologia Quimica e Biologica-Universidade Nova de Lisboa (Portugal). In his thesis research work he applied and developed several computational methods to design novel functional proteins. Bruno Correia joined the EPFL’s Institute of Bioengineering in 2015 as Tenure Track Assistant Professor, and was promoted to Associate Professor in Bioengineering in 2021.
As Head of the Laboratory of Protein Design & Immunoengineering (LPDI) at EPFL’s Institute of Bioengineering (School of Engineering), Bruno Correia has developed and directed cutting edge research in protein design. Targeting practical applications in therapeutics, vaccines or biosensing, he and his team are striving on the one hand to expand nature’s repertoire by designing novel functional proteins (bottom-up de novo protein design), and on the other to functionally repurpose proteins pre-existing in the natural repertoire. The original methods Correia and his coworkers have developed and refined, which combine in silico, in vitro and in vivo approaches, have earned them a world-wide reputation as leading experts in protein synthesis, vaccine design and gene therapy research.
Bruno Correia is Laureate of the 2021 EPFL University Latsis Award for his contributions in interfacing protein design with immunoengineering. Some of his work has unveiled novel routes for the development of new vaccine concepts and cell-based therapies.
Bruno Correia joined the NCCR Chemical Biology in 2018. He is a member of the NCCR equal opportunity committee.
Discover more about Bruno Correia’s research on his lab website.
Ecole polytechnique fédérale de Lausanne
EPFL STI IBI-STI LPDI
AAB 2 44 (Bâtiment AAB)
1015 Lausanne, Switzerland
Phone: +41 (0)21 693 61 66